| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/13/2004 | CN1535722A Colostrum peptide and its application |
| 10/12/2004 | US6803203 Protein kinases; for monitoring in vitro activity in eukaryotic cells; drug screening; kits |
| 10/07/2004 | WO2004085653A1 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 10/07/2004 | WO2004085465A1 Phex substrates and methods using same |
| 10/07/2004 | WO2004085461A2 Tumour-associated peptides binding to mhc molecules |
| 10/07/2004 | WO2004085272A1 Lock for a flat and low pourer provided with a removable element in the form of a laminate of film for a composite package for container openings closed by a nonpermeable film |
| 10/07/2004 | WO2004084812A2 Tamandarin analogs and fragments thereof and methods of making and using |
| 10/07/2004 | WO2004084800A2 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use |
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
| 10/07/2004 | WO2003090697A3 Chimeric hybrid analgesics |
| 10/07/2004 | WO2003062420A8 Molecular libraries |
| 10/07/2004 | WO2003059942A3 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040198666 Novel selective bradykinin (BK) B1 peptidic receptor antagonists and uses thereof |
| 10/07/2004 | US20040197838 for creating this postranslational modification in vivo; genetic engineering; solid phase synthesis; kits |
| 10/07/2004 | US20040197798 Using alteration in phosphorylation to detect, diagnose, prevent and prognose cell proliferative disorders |
| 10/07/2004 | US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 10/07/2004 | US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses |
| 10/07/2004 | DE10313819A1 An MHC-Moleküle bindende Tumor-assoziierte Peptide Binding to MHC molecules tumor-associated peptides |
| 10/07/2004 | CA2731275A1 Tumour-associated peptides binding to mhc-molecules |
| 10/07/2004 | CA2520497A1 Tumour-associated peptides binding to mhc molecules |
| 10/07/2004 | CA2519826A1 Cell death-inducing fusion gene specifically acting on cancer and product thereof |
| 10/07/2004 | CA2519234A1 Tamandarin analogs and fragments thereof and methods of making and using |
| 10/06/2004 | EP1463812A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 10/06/2004 | EP1463529A2 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 10/06/2004 | EP1463521A2 Gp41 inhibitor |
| 10/06/2004 | EP1051433B1 Antimicrobial peptides |
| 10/06/2004 | EP0904541B1 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
| 10/06/2004 | EP0869810B1 Cyclosporin-containing soft capsule preparations |
| 10/06/2004 | CN1535281A Peptides and related molecules that bind to TALL-1 |
| 10/06/2004 | CN1535168A Controlled release composition and method of producing the same |
| 10/06/2004 | CN1534042A Preparation method of thymopentapeptide |
| 10/06/2004 | CN1169966C Isolated, tyrosinase derived peptides and uses thereof |
| 10/06/2004 | CN1169959C Polypeptide variants with raised heparin-binding capacity |
| 10/06/2004 | CN1169829C Non-T cell conjugating peptide and its use |
| 10/06/2004 | CN1169828C Disinfecting/permeability improved peptide allosteric in protein function region |
| 10/06/2004 | CN1169827C Method for improving stability of polypeptide in body and its application |
| 10/05/2004 | US6800745 For microbiocides |
| 10/05/2004 | US6800727 Peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof |
| 10/05/2004 | US6800492 Wherein linkage between proteins (aequorin and green fluorescent protein (gfp)) stabilizes the system and allow energy transfer via chemiluminescence resonance energy transfer |
| 10/05/2004 | US6800481 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 10/05/2004 | US6800434 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 10/05/2004 | US6800287 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 10/01/2004 | CA2423876A1 Novel selective bradykinin (bk) b1 peptidic receptor antagonists and uses thereof |
| 09/30/2004 | WO2004083243A1 Amylin aggregation inhibitors and use thereof. |
| 09/30/2004 | WO2004083236A2 Cancer treatment using proanp peptides |
| 09/30/2004 | WO2004082701A1 New engineered antibiotic peptide and its preparing process |
| 09/30/2004 | WO2004082629A2 Novel cyclosporins |
| 09/30/2004 | WO2004050689A3 Aza-peptides |
| 09/30/2004 | WO2003073097A3 Methods for isolating ligands e.g. t cell epitopes |
| 09/30/2004 | WO2003072593A3 Bone targeting peptides |
| 09/30/2004 | WO2003004141A3 Kinase mimic catalysts for asymmetric synthesis of phosphorylated insitols and cycloalkanols |
| 09/30/2004 | US20040192901 Using superoxide dismutase to identify modulators for treatment of diabetes, scrapies, transmissible spongiform encephalopathies and alzheimer's diseases |
| 09/30/2004 | US20040192611 amino acid sequence GVAWWM*; and GVAWWM*Y; wherein M* is methionine sulfoxide; use reducing oxidative degradation of fats or oils, or providing an antioxidant to a person in either pharmaceutical or dietary compositions |
| 09/30/2004 | US20040192608 Treatment of obesity |
| 09/30/2004 | US20040192596 Therapeutic fibrin-derived peptides and uses thereof |
| 09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
| 09/30/2004 | US20040191272 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 09/30/2004 | US20040191268 Isolated, synthetic or recombinant nonapeptide of a minor Histocompatability antigen HA-1 comprising the sequence valine-leucine-X-aspartic acid-aspartic acid-leucine-leucine-glutamic acid-alanine wherein X is arginine or histidine; bone marrow transplants; graft versus host disease; leukemia |
| 09/30/2004 | CA2518550A1 Cancer treatment using proanp peptides |
| 09/30/2004 | CA2518265A1 Novel cyclosporins |
| 09/30/2004 | CA2516726A1 Amylin aggregation inhibitors and use thereof |
| 09/29/2004 | EP1462456A1 Tumor antigens |
| 09/29/2004 | EP1462455A1 Novel peptides and medicinal uses thereof |
| 09/29/2004 | EP1461356A2 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1425575A4 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 09/29/2004 | EP1350428B1 Portable, motor-powered shears |
| 09/29/2004 | EP1015012A4 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 09/29/2004 | EP0983300B1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/29/2004 | EP0675903B1 Bone resorption assay |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1532207A Polyethylene glycol derivatives of thymosin alphal |
| 09/29/2004 | CN1532206A Active fragment of thymosin alphal and its polyethylene glycol derivatives |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 09/28/2004 | US6797860 Promoter derived from phytosulfokine precursor gene |
| 09/28/2004 | US6797522 Solid phase synthesis; libraries; enzyme inhibitors; chromatography |
| 09/28/2004 | US6797272 Enhanced immunogenicity using leukotoxin chimeras |
| 09/28/2004 | CA2458081A1 Peptide antioxidants from soy protein |
| 09/28/2004 | CA2162557C Conserved motif of hepatitis c virus e2/ns1 region |
| 09/23/2004 | WO2004081188A2 Non-toxic membrane-translocating peptides |
| 09/23/2004 | WO2004081030A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 09/23/2004 | WO2004080492A1 Methods of radiofluorination of biologically active vectors |
| 09/23/2004 | WO2004080288A2 Post-translational modifications of proteins as regulatory switches |
| 09/23/2004 | WO2004052915A3 Novel cyclic peptides comprising alpha-, beta- and gamma- amino acids |
| 09/23/2004 | WO2004007671A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 09/23/2004 | WO2003093294A3 Conformationally constrained peptides that bind the orl-1 receptor |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003059436A3 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 09/23/2004 | WO2003005956A3 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 09/23/2004 | US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 09/23/2004 | US20040186274 Methylation of histone h4 at arginine 3 |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186057 Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |